A detailed history of Quantamental Technologies LLC transactions in Incyte Corp stock. As of the latest transaction made, Quantamental Technologies LLC holds 4,147 shares of INCY stock, worth $289,916. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,147
Previous 18,194 77.21%
Holding current value
$289,916
Previous $1.13 Million 78.89%
% of portfolio
0.23%
Previous 0.48%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $811,495 - $926,118
-14,047 Reduced 77.21%
4,147 $239,000
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $2,925 - $3,624
-48 Reduced 0.26%
18,194 $1.13 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $594,848 - $728,504
8,470 Added 86.68%
18,242 $1.32 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $196,232 - $245,685
2,921 Added 42.64%
9,772 $784,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $453,399 - $567,673
6,851 New
6,851 $457,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $201,294 - $243,035
-3,049 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $120,726 - $141,253
-1,906 Reduced 38.47%
3,049 $224,000
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $340,259 - $416,319
4,955 New
4,955 $341,000
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $457,149 - $553,177
-5,662 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $481,666 - $621,064
5,662 New
5,662 $508,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $186,178 - $243,990
-2,549 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$72.82 - $86.52 $81,194 - $96,469
1,115 Added 77.75%
2,549 $189,000
Q2 2019

Aug 12, 2019

SELL
$73.52 - $88.7 $626,390 - $755,724
-8,520 Reduced 85.59%
1,434 $122,000
Q1 2019

Apr 29, 2019

BUY
$63.56 - $88.17 $480,513 - $666,565
7,560 Added 315.79%
9,954 $856,000
Q4 2018

Jan 28, 2019

BUY
$58.5 - $69.94 $140,049 - $167,436
2,394 New
2,394 $152,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.